Data crunched by an online pharmacy delivery company paints a concerning picture for the pharmacy sector in England.
Gophr's 'Prescription For Pressure' initiative reveals a challenging time for the sector and is supported by separate analysis by the BBC showing that the number
of pharmacies in England is at its lowest since 2010.
In addition, new powers being introduced for pharmacists to prescribe common prescription drugs and perform routine tests create an even greater workload for already
overstretched pharmacists.
Gophr's data reveals that:
* Each pharmacy in England serves an average of 6,078 people.
* In 2022, pharmacists dispensed 1.043 billion prescriptions, 26.3 million more than 2021.
* A single pharmacy in England dispensed 248 prescriptions a day on average in 2022.
Based on the most up-to-date statistics from the Office for National Statistics, NHS England and Statista, Gophr's calculations show that pharmacists have around 116
seconds to dispense a prescription, which is less time than the 180 seconds it takes to make a Quarter Pounder at McDonald's.
Online pharmacy Pharmacy2U, acquires LloydsDirect in a merger for a single digital-first pharmacy.
The companies issued a statement on 9 October and confirmed that they would operate as Pharmacy2U.
It would also have a total of 1.4 million EPS nominations, as confirmed by NHS recent data.
They are planning to enhance patient accessibility to online pharmacy and healthcare services through their combined services.
Kevin Heath, Chief Executive Officer of Pharmacy2U, said: "We are delighted to welcome the LloydsDirect team into the Pharmacy2U family. Combining the best
of both of our businesses, we can provide patients with greater access and convenience.
Pharmacy2U has recently acquired LloydsDirect in a confidential deal, bringing together two of the UK's foremost online pharmacies. Over time, both entities
will integrate their operations under the Pharmacy2U brand, the companies said in a joint statement.
The two businesses complement each other effectively, and their teams will now work closely together to uphold the patient-centric approach and service quality
for which both are known individually, the statement added. However, there is currently limited clarity regarding the sale process and its impact on Lloyds staff.
According to NHS Business Services Authority data from PharmData, Pharmacy2U dispensed 1,528,436 items in June 2023, while LloydsDirect, previously owned by
LloydsPharmacy, dispensed 1,142,891 items. This positions them as the top two online prescription pharmacies for items dispensed, with Well.co.uk in third place
at 128,691 items.
People in the UK have a high level of trust in pharmacies and many are keen on seeing the Pharmacy First initiative expanded, according to the 2024 STADA
Health Report published today (24 June).
The 10th annual health report by global healthcare leader STADA Arzneimittel AG, the parent company of Thornton & Ross, involved a survey of over 46,000
respondents across 23 countries, including 2,000 participants from the UK.
The UK data showed an overwhelming trust in UK pharmacies, with 94 per cent of those surveyed (more than nine out of 10 Brits) saying they have only ever had
good advice from a pharmacist.
The report also indicated a strong desire for the Pharmacy First scheme to be expanded, with 44 per cent of respondents advocating for an increase in pharmacists'
scope of responsibilities to support doctors.
The Pharmaceutical Services Negotiating Committee (PSNC) and NHS England have agreed that community pharmacy contractors will have to participate in one
mandatory national health campaign.
This campaign on weight management commenced from Tuesday (03 January) and will run until Sunday (29January).
PSNC said: "Pharmacies can be required to participate in up to six health campaigns at the request of NHS England per year (1st April to 31st March).
Pharmacies will be involved by displaying and distributing leaflets provided by NHS England.
In addition, pharmacies are required to undertake prescription-linked interventions on major areas of public health concern, such as encouraging smoking cessation.
"Contractors can order pharmacy specific posters, wallet cards ('info' cards with a QR code signposting people to the Better Health website and free tips and tools
to lose weight) and a dispenser for these cards on the Campaign Resource Centre website. A guidance leaflet to support community pharmacy teams' conversations with
patients is also available," said PSNC.
The price concession for Atorvastatin 80mg has been increased to £3.91 from the previously set £3.45 for prescriptions dispensed in July, the Community Pharmacy
England has said. The Department of Health and Social Care additionally introduced a concession price of £3.38 for Atorvastatin 20mg.
"In July, our Dispensing and Supply Team experienced an unusually high influx of reports from pharmacies struggling to acquire Atorvastatin 80mg tablets at the
listed Drug Tariff price," said CPE.
CPE requested a price concession early in the month. However, after extended discussions, an agreement on the price wasn't reached. Consequently, on July 31st, the
DHSC imposed a concession of £3.45.
Addressing enduring pharmacy concerns over the pricing, CPE intensified advocacy with DHSC. This endeavour resulted in the revision of the Atorvastatin 80mg tablet
concession price to £3.91 for prescriptions submitted and dispensed in July.
According to CPE, this adjusted price sufficiently covers costs as reported by the majority of pharmacy owners.
However, DHSC has refrained from modifying concessionary prices for the other two requested lines by CPE. DHSC communicated that their team's data collection for
July, employing real-time sales and volume data, was incongruent with the adjustment of these prices, CPE further said.
Community pharmacies were responsible for dispensing over 99 per cent of items in 2022/23, revealed General Pharmaceutical Services for Northern Ireland,
Annual Statistics 2022/23 published on Thursday (29 June).
While the remaining one per cent dispensed by appliance contractors and dispensing doctors.
According to the statistics, on average, each community pharmacy dispensed over 84,000 items in 2022/23, witnessing a growth of over 3 per cent on the previous
year to 44.6 million in 2022/23, which is the highest level of dispensing recorded.
This equated to BSO processing 2.1 million prescription forms per month, on average, throughout the year, representing a 4 per cent increase on the just over
2.0m processed each month last year.
The total ingredient cost over the year was £486.9 million. This was an increase of approaching 7 per cent on the previous year, which was around double the
percentage increase in the number of items dispensed. The annual ingredient cost total has fluctuated since the beginning of the series but was over
18 per cent higher in 2022/23 than in 2013/14.
In a recent report released by the Company Chemists' Association (CCA), data from the NHS Pharmacy First service indicates a substantial uptake and
positive impact on patient care just two months after its launch.
The CCA's findings shed light on the service's efficacy in meeting patient needs and its potential to alleviate pressure on General Practices (GPs) within the NHS.
According to the report, over 90,000 Pharmacy First consultations were conducted solely by CCA members within the initial two-month period.
Impressively, 88 per cent of these consultations, totaling 81,627, were deemed eligible for NHS-funded care indicating a significant demand for the service among
patients.
In the first month, the data revealed that more than 90 per cent of eligible patients received necessary care directly through Pharmacy First, bypassing the
need for further referral.
The recent data released by the NHS England revealed that in 2022/23 nearly 86 million antidepressant items were prescribed to around 8.6 million identified
patients.
According to the statistic published on 'Medicines Used in Mental Health' of the 5 British National Formulary (BNF) sections, 4 had increases in items and identified
patients across 2022/23.
The only BNF section to decrease since 2021/22 was hypnotics and anxiolytics. Items fell by 2% to 14 million and identified patients fell by 2 per cent to 1.9 million
in 2022/23
The data also revealed that Prescribing of Central Nervous System (CNS) stimulants and drugs for ADHD increased by 32 per cent in adults over 18 and 12 per cent in
children 17 and under.
"2022/23 was the first time that more adult patients have been prescribed drugs from this section than child patients, in the time period covered by these
statistics," said the report.
Nearly half of Type 1 diabetes patients in the NHS England are benefiting from the use of flash monitors that allow them to check their glucose levels more easily and regularly.
The wearable gadget, linked with a phone app, has a sensor that attaches to the back of the arm, allowing patients to check their glucose with a simple one-second scan.
Eligible patients can access the monitors on prescription from their local GP or diabetes team.
The NHS is ahead of target to roll-out the monitors, as the independent health advisory NICE, confirmed it was beginning the consultation to expand the kit's access.
As per recent data, around 125,000 patients now uses these monitors to help control their condition. The latest number shows that the NHS significantly exceeded its
user target with more than 45 per cent of patients using the monitor.
The Hormone Replacement Therapy (HRT) Taskforce head Madelaine McTernan has returned to working full time as the director general of the Vaccine Taskforce for
autumn booster campaign preparation.
She has presented a few key recommendations to help ensure continued HRT supply to meet rising demand. "Improved access to data on prescriptions to more easily see
where there are shortfalls between HRT packs prescribed and HRT packs supplied by manufacturers," she suggested. "Taking lessons from the HRT supply chain work to
inform broader medicine supply work."
Madelaine said: "I am pleased to see the situation with HRT supply is improving across the country. I want to thank suppliers and manufacturers for their engagement
and positive action to tackle this serious issue.
The National Health Service (NHS) has said that the roll-out of blood-thinning drugs has helped save thousands of lives.
In January 2022, the NHS launched a drive to rapidly expand the use of life-saving direct oral anticoagulants (DOACs) in people who are at increased risk of strokes.
Since then, more than 24 million prescriptions have been given to such patients and around 460,000 more people have started taking the drugs.
This prevented an estimated 17,000 strokes and 4,000 deaths in the last 18 months, as revealed by the new NHS data.
Amanda Pritchard, the NHS chief executive, hailed the "lifesaving NHS rollout" at the King's Fund annual conference.
It is part of a major NHS drive on "prevention" - to catch more killer conditions earlier and save more lives.